Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Lipocine Inc. (LPCN)

Pharmaceutical Preparations

http://www.lipocine.com

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

675 ARAPEEN DRIVE, SUITE 202
SALT LAKE CITY, X1

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/05/2012

Market Cap

19,519,981

Shares Outstanding

5,320,000

Weighted SO

5,315,830

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.1180

Last Div

0.0000

Range

2.31-11.79

Chg

-0.0100

Avg Vol

50720

Mkt Cap

19519981

Exch

NASDAQ

Country

US

Phone

801 994 7383

DCF Diff

2.7525

DCF

0.8975

Div Yield

0.0000

P/S

4.2071

EV Multiple

-1.4663

P/FV

0.9197

Div Yield %

0.0000

P/E

-2.2979

PEG

0.0462

Payout

0.0000

Current Ratio

12.5604

Quick Ratio

12.5604

Cash Ratio

3.0447

DSO

5.0061

DIO

0.0000

Op Cycle

5.0061

DPO

27.1849

CCC

-22.1788

Gross Margin

-0.2987

Op Margin

-2.1268

Pretax Margin

-1.8292

Net Margin

-1.8295

Eff Tax Rate

0.0008

ROA

-0.3685

ROE

-0.3858

ROCE

-0.4653

NI/EBT

1.0001

EBT/EBIT

0.8601

EBIT/Rev

-2.1268

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-24669.8650

CF/Debt

0.0000

Equity Multi

1.0860

Rec Turnover

72.9106

Pay Turnover

13.4266

Inv Turnover

0.0000

FA Turnover

46.8325

Asset Turnover

0.2014

OCF/Share

-0.8830

FCF/Share

-0.8847

Cash/Share

4.2195

OCF/Sales

-1.0170

FCF/OCF

1.0019

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-514.7370

Div&CapEx Cov

-514.7370

P/BV

0.9197

P/B

0.9197

P/S

4.2071

P/E

-2.2979

P/FCF

-4.1288

P/OCF

-4.1337

P/CF

-4.1337

PEG

0.0462

P/S

4.2071

EV Multiple

-1.4663

P/FV

0.9197

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation